Aniela Popescu/LinkedIn
Aug 29, 2026, 15:43
Aniela Popescu: Heart Failure Care Enters a New Era With the 2026 ESC Guidelines
Aniela Popescu, Fellow of the European Society of Cardiology at European Society of Cardiology, shared a post on LinkedIn:
“Hot off the press: new 2026 ESC Heart Failure Guidelines from ESC Congress 2026!
A new way of thinking about heart failure, with more emphasis on prevention, phenotyping and individualized treatment.
Some of the key messages:
- Simplified HF classification: HFrEF less than 50 percent and HFpEF greater than or equal to 50 percent
- Greater focus on prevention and pre-heart failure
- A more multiparametric diagnostic approach, integrating biomarkers and multimodality imaging, with greater emphasis on natriuretic peptides
- New treatment terminology: Foundational Medical Therapy (FMT) as the therapeutic backbone, complemented by Additional Medical Therapy (AMT) and Guideline-Directed
Interventional Therapy (GDIT)
- SGLT2 inhibitors and MRAs as foundational therapy in symptomatic HF, irrespective of LVEF
- ‘Decompensated heart failure’ replaces ‘acute heart failure’, encompassing both acute and gradual worsening requiring urgent treatment
- Greater integration of device and interventional therapies, with CRT potentially considered earlier in appropriate patients
A shift towards earlier recognition, better phenotyping and a more integrated, personalized approach to heart failure care.
More updates from Munich to come!”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question